search
Back to results

Clinical Trials of Regeneration for Periodontal Tissue

Primary Purpose

Adult Periodontitis

Status
Completed
Phase
Phase 1
Locations
Japan
Study Type
Interventional
Intervention
surgical operation of cell transplantation
Sponsored by
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Adult Periodontitis focused on measuring Regenerative medicine, Periodontal tissue

Eligibility Criteria

35 Years - 60 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria: 1.Patient with adult periodontitis. 2. There are 4mm or more pocket using . 3.There are ten existing tooth or more of the lower jaw. 4.The brushing instruction is received, and the plaque control is maintained excellently. 5.The recovery by an existing periodontal operation cannot be expected. 6.The age is from 35 to 60 years old. 7.Blood clot function is normal. 8.The liver function is normal. 9.The intention and the ability of going to hospital regularly are possessed. 10.Agreement by the document is obtained. Exclusion Criteria: 1.Patient who has acute symptom of periodontitis. 2.Patient that decayed tooth is on teeth or the next teeth to be treated. 3.Patient who has contracted diabetic or autoimmune disease. 4.Patient who has contracted infectious disease. 5.Patient who has contracted osteoporosis. 6.Patient who has smoking habit within six months before it registers. 7.Patient who is taking treatment of hypertension and/or epilepsy. 8.Patient who has pregnancy or doubt of pregnancy. 9.Patient who has heavy allergic disease.

Sites / Locations

  • Institute of Biomedical Research and Innovation

Outcomes

Primary Outcome Measures

Alveolar bone defect

Secondary Outcome Measures

Tooth mobility

Full Information

First Posted
September 13, 2005
Last Updated
February 6, 2009
Sponsor
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Collaborators
ArBlast Co.,Ltd., Nagoya University
search

1. Study Identification

Unique Protocol Identification Number
NCT00221130
Brief Title
Clinical Trials of Regeneration for Periodontal Tissue
Official Title
Clinical Trial of Regenerative Periodontal Tissue by Transplanting Mesenchymal Stem Cells and Osteoblast Cells - I, II Phase-
Study Type
Interventional

2. Study Status

Record Verification Date
February 2009
Overall Recruitment Status
Completed
Study Start Date
July 2004 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
December 2005 (undefined)

3. Sponsor/Collaborators

Name of the Sponsor
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Collaborators
ArBlast Co.,Ltd., Nagoya University

4. Oversight

5. Study Description

Brief Summary
Adult periodontitis is a chronic infective disease affecting the periodontium. Periodontitis induce the destruction of attachment apparatus of teeth, resulting in periodontal pocket formation and teeth loss. This study will test the safety and efficacy of alveolous bone reproduction by the transplantation of mixture named periodontium injectable gel for the adult periodontitis patients. Injectable gel is the mixture of ex-vivo cultured mesenchymal stem stem cells, ex-vivo cultured osteoblast-like cells differentiated from mesenchymal stem cells and scaffold (include, platelet rich plasma, human thrombin and calcium chloride).
Detailed Description
Periodontal disease is an infectious disease. Gingivitis and periodontitis are the 2 major forms of this. Their primary etiology is bacterial plaque, which can induce destruction of the periodontal apparatus. Gingivitis is inflammation of the gingival that does not result in clinical attachment loss. Periodontitis is inflammation of the gingival and is characterized by loss of connective tissue attachment and alveolar bone. Therapeutic approaches for periodontitis are divided into two categories: 1) anti-infective treatment; 2) regenerative therapy. Several surgical techniques have been developed to regenerate periodontal tissues including guided tissue regeneration, bone grafting, the use of enamel matrix derivative. However, these techniques are not reached for complete regeneration of the periodontium. This study will test the safety and efficacy of alveolous bone reproduction by the transplantation of mixture named periodontium injectable gel for the adult periodontitis patients. Injectable gel is the mixture of ex-vivo cultured mesenchymal stem stem cells, ex-vivo cultured osteoblast-like cells differentiated from mesenchymal stem cells and scaffold (include, platelet rich plasma, human thrombin and calcium chloride).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Adult Periodontitis
Keywords
Regenerative medicine, Periodontal tissue

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 1, Phase 2
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
10 (false)

8. Arms, Groups, and Interventions

Intervention Type
Procedure
Intervention Name(s)
surgical operation of cell transplantation
Primary Outcome Measure Information:
Title
Alveolar bone defect
Secondary Outcome Measure Information:
Title
Tooth mobility

10. Eligibility

Sex
All
Minimum Age & Unit of Time
35 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: 1.Patient with adult periodontitis. 2. There are 4mm or more pocket using . 3.There are ten existing tooth or more of the lower jaw. 4.The brushing instruction is received, and the plaque control is maintained excellently. 5.The recovery by an existing periodontal operation cannot be expected. 6.The age is from 35 to 60 years old. 7.Blood clot function is normal. 8.The liver function is normal. 9.The intention and the ability of going to hospital regularly are possessed. 10.Agreement by the document is obtained. Exclusion Criteria: 1.Patient who has acute symptom of periodontitis. 2.Patient that decayed tooth is on teeth or the next teeth to be treated. 3.Patient who has contracted diabetic or autoimmune disease. 4.Patient who has contracted infectious disease. 5.Patient who has contracted osteoporosis. 6.Patient who has smoking habit within six months before it registers. 7.Patient who is taking treatment of hypertension and/or epilepsy. 8.Patient who has pregnancy or doubt of pregnancy. 9.Patient who has heavy allergic disease.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Shunsuke Baba, D.D.S, PhD
Organizational Affiliation
Institute of Biomedical Research and Innovation
Official's Role
Principal Investigator
Facility Information:
Facility Name
Institute of Biomedical Research and Innovation
City
Kobe
State/Province
Hyogo Pref.
ZIP/Postal Code
650-0047
Country
Japan

12. IPD Sharing Statement

Links:
URL
http://www.ibri-kobe.org/english/index.html
Description
Introduction of theFoundation for Biomedical Research and Innovation

Learn more about this trial

Clinical Trials of Regeneration for Periodontal Tissue

We'll reach out to this number within 24 hrs